David has been with Sentara Healthcare, a $5 billion integrated health system with more than 100 diversified healthcare facilities across Virginia and North Carolina, since 1973 and has served as the CEO of Sentara since 1994. Under his leadership, Sentara was ranked the number one integrated healthcare network in the United States in 2010 and 2011 by Modern Healthcare magazine, and is the only healthcare system in the nation to be named in the top 10 for 15 years. Along with overseeing Sentara, David is an active member in the American Hospital Association, and served as the chairman of the board of trustees in 2004. His extensive operational experience and unique purview of the U.S. healthcare system are of great value to the Gryphon team across a broad spectrum of opportunities, particularly in multi-site services and outsourced hospital services, two areas of proactive focus.
Gary Blackford – CEO, Universal Hospital Services
Gary served as Chairman and CEO of Universal Hospital Services (“UHS”) from 2002 through 2015. During his tenure he transformed the company from a regional medical equipment rental business to a national leader in providing medical equipment outsourcing and life cycle solutions to more than 8,000 hospitals and alternative care providers. Before joining UHS, Gary served as CEO of Curative Health Services, a specialty pharmacy and health services company. He was also the EVP and COO for ValueRx, a $2 billion pharmacy benefit management company, where he was instrumental in restructuring the business before its sale to Express Scripts in 1998. In addition, he held positions at ShopforSchool, MedIntell Systems Corporation, Residential Services Corporation of America, and Popham, Haik & Kaufman. He currently serves on the Board of Directors at Halyard Health and Wright Medical Technologies. He holds a B.B.A. from the University of Iowa, a J.D. from Creighton University, and is a Certified Public Accountant.
Joseph Cashia – Former CEO, National Renal Alliance
Joseph has over 35 years of leadership experience partnering with physicians and hospitals in outpatient services. In his professional career he has held executive roles for several healthcare services providers that have successfully executed buy-and-build strategies including Vivere Health (Chairman and CEO); National Renal Alliance (founder, Chairman and CEO); National Nephrology Associates (founder and COO); Renal Care Group (founder and COO); and REN CORP – USA (COO). Joseph has been named a Top 100 Healthcare Executive by the Nashville Business Journal and has won several regional and national awards for his business success. He has led successful business strategies that have involved Private Equity, Initial Public Offerings, and utilized both public as well as private debt. Joseph attended Samford University (B.S., Nursing) and Vanderbilt University’s Owen Graduate School of Management (Masters Business Administration).
Dan Cave – Former CEO & President of Envolve Peoplecare (a division of Centene Corporation)
Dan is the former CEO & President of Envolve Peoplecare, a national consumer-focused specialty health services company owned by Centene Corporation. He has over 35 years of experience with health services businesses, serving in CEO positions for more than 25 of those years for startup/early stage and mid-size companies as well as large corporate business units. Prior to his role at Envolve, Dan served as CEO & President of Nurtur Health, CEO & President of Cardium Health Services, COO of CIGNA Pharmacy Management, and President of Specialty Companies at Prudential Healthcare, in addition to other roles. Dan is currently a member of the Board of Directors at Gryphon portfolio company LEARN Behavioral, and works with the Gryphon team to evaluate opportunities in payor services, behavioral healthcare and healthcare IT in addition to other areas of focus.
Ronald J. Kuerbitz – Current CEO, agilon health; Former CEO, Fresenius Medical Care North America
Ron is currently CEO of agilon health, a healthcare services and technology company that partners with physicians to create value-based healthcare delivery systems. From 2013 through 2016, Ron served as CEO of Fresenius Medical Care North America. Under his leadership, the organization become the country’s leading provider of integrated health care services for renal patients, and he grew the capabilities of FMCNA to include hospitalist medicine, cardiovascular care, and programs designed to flourish in a consumer and value driven health care system. Ron joined Fresenius in 1997 to lead its corporate development function and was later named as the division’s General Counsel and Chief Administrative Officer before assuming an Executive Vice President role. Ron is a graduate of Albion College and received his Juris Doctor Degree from the Yale Law School. His notable experience in healthcare operations and leadership serves the Gryphon team in evaluating opportunities in payor services, physician practice management, and outsourced hospital services among other areas of focus.
Dan Greenleaf – CEO, BioScrip
Dan has over two decades of experience in senior leadership positions across the healthcare industry and is currently serving as Chairman and CEO of BioScrip, one of the nation’s top performing home infusion companies. Prior to BioScrip, he served as President and CEO of Coram Specialty Infusion Services as well as Chief Operating Officer for Apria Healthcare. Under Dan’s leadership, Coram grew its revenue organically from $600 million to $1.2 billion and increased earnings by more than 250%, resulting in an increase in enterprise value from $350 million to over $2.0 billion. Prior to joining Apria/Coram, Dan served as President and Chief Executive Officer for VioQuest Pharmaceuticals, a publicly traded biopharmaceutical company. Additionally, Dan has held senior leadership roles at Celltech Biopharmaceuticals, Nabi Pharmaceuticals, and Schering-Plough Corporation. Dan serves on the University of Miami’s Health Sector Management Policy Board, Denison University’s Board of Advisors, Rotech Healthcare’s Board, and is a past board member for the National Home Infusion Association. Dan holds a M.B.A. in Health Administration from the University of Miami and a B.A. in Economics from Denison University. He is a veteran of the U.S. Air Force and served in Operation Desert Storm.
David M. Lawrence, MD – Former CEO and Chairman, Kaiser Foundation Health Plan and Hospitals
Dr. Lawrence joined Kaiser Permanente in 1981 and served as CEO and Chairman of Kaiser Foundation Health Plan and Hospitals from 1991 until his retirement in 2002. He is a member of the boards of Agilent Technologies, McKesson Corporation, Proventys, Wellpartner, and Proteus Biomed. He is a member of the Scientific Advisory Board for the Burrill and Co. Life Sciences Fund, serves as an advisor to the CEO’s of SomaLogic, Inc., and MedExpert, Inc., and teaches with the Estes Park Institute. As the former head of the largest integrated medical care system in the U.S., Dr. Lawrence has a uniquely broad perspective on the healthcare industry.
Jay Martus – Former President, Advantia Health
Jay Martus previously served as an Executive Vice President at Sheridan Healthcare, where, for 25 years, he grew Sheridan from a small regional provider to one of the largest hospital-based physician services companies in the nation. Mr. Martus is a nationally recognized healthcare leader, lecturer, and editor, and a leading edge managed care negotiator and M&A dealmaker. Mr. Martus earned his J.D. from the University of Miami’s School of Law (summa cum laude) and graduated cum laude from the University of Massachusetts, Amherst with a B.A. in Economics.
Stephen Newman, MD – Former Vice Chairman and COO, Tenet Healthcare Corporation
Dr. Newman has over 20 years of executive experience within the health care service industry. He most recently retired as Vice Chairman of Tenet Healthcare, a health care services company operating over 50 hospitals and 117 outpatient centers across 11 states. Prior to becoming the Vice Chairman, Dr. Newman was the COO of Tenet, and was instrumental in executing a significant turnaround of the company’s financial and operating performance. Dr. Newman is currently on the Board of Directors of three publicly traded healthcare companies: Optimer Pharmaceuticals, Hansen Medical and Cadence Pharmaceuticals. His extensive background and experience with a large health care delivery system allows Dr. Newman to assist the Gryphon team in evaluating opportunities in the key focus sectors of multi-site services and outsourced hospital services.
Jerry Rhodes – Former CEO, CRC Health Group
Jerry Rhodes has over 30 years of experience in the healthcare industry and over 25 years in behavioral healthcare. Most recently, Jerry was named CEO of CRC after joining the company in 2003 and serving as both President of the highly successful Recovery Division and later COO. Prior to joining CRC, he was the Chief Executive Officer for Comprehensive Addictions Programs Inc. (CAPs) for ten years. CAPs was a privately held company backed by several private equity investors that, under Rhodes’ leadership, became a national, full-service addiction treatment provider of both residential and opiate treatment. The company was acquired by CRC in February 2003. Prior to his CEO role at CAPS, Rhodes was the Vice President of Operations for two years and the Senior Vice President of Acquisitions and Development for two years. Before joining CAPS, Rhodes was the Director of Development for Beverly Enterprises, the nation’s largest publicly held nursing home company, for four years. Jerry was responsible for all new facility projects and developed over 40 facilities and the acquisition of another 50 facilities. Prior to this position, he was the Chief Development Consultant with Wilmot Bower & Associates, a nationally renowned Architectural and Development firm specializing in healthcare facilities. He is a member of the Board of Directors of the National Association of Psychiatric Health Systems, National Association of Addiction Treatment Providers and is a recipient of the prestigious Nyswander Dole Award from American Association for the Treatment of Opioid Dependence in 2012. He serves on the board of several companies engaged in behavioral health and long term care.
Russ Rudish – Former Global Health Care Leader, Deloitte Touche Tohmatsu Limited
Russ Rudish has more than 30 years of experience in serving the health care industry, both in the United States and abroad. Russ most recently served as the Global Health Care Leader for Deloitte Touche Tohmatsu Limited, the largest health care professional services firm in the world. While at Deloitte, Russ served many of the firm’s largest clients across the globe, specializing in Strategy, Growth, M&A, Cost Reduction, Revenue Maximization, Clinical Quality and IT Planning and Execution. Prior to joining Deloitte in 2006, Russ was Executive Vice President of Eclipsys Corporation, a $400M NASDAQ healthcare software, tech and services provider that has since merged with Allscripts. Prior to that, Russ was at Cap Gemini Ernst & Young and its predecessor firm Ernst & Young, LLC, where he was a CPA and audit partner for almost 20 years and led the Health Care Practice in the US and Europe. Russ is also on the Board of Directors of Craneware, Inc., a health care company on the London Stock Exchange focused on revenue integrity, and is a member of the Health Information Management Systems Society and the Healthcare Financial Management Association. He is a graduate of St. John’s University in New York City and is active in community affairs and charitable organizations. Russ’ extensive managerial and operational experience has proven immensely helpful to Gryphon, particularly in evaluating opportunities in outsourced hospital services, an area of proactive focus for the firm.
Greg Scott – Current Executive Chairman at Adeptus Health; Former CEO of APS; Former CFO of PacifiCare Health Systems
Greg is currently Executive Chairman at Adeptus Health, a leading patient-centered healthcare organization expanding access to the highest quality emergency medical care through its network of freestanding emergency rooms and partnerships with premier healthcare providers. Prior to Adeptus, Greg was CEO of APS Healthcare, a specialty healthcare services provider to Medicaid agencies, that was acquired by Universal American. Prior to APS, Greg served as CFO at multiple corporations, including PacifiCare Health Systems, Medsite and Prudential Healthcare. Greg works with the Gryphon team to evaluate payor services opportunities in addition to other areas of focus.
Adam Singer – Former CEO, IPC Healthcare, Inc.
Adam has been a highly successful physician and healthcare entrepreneur. In 1991, he had been a pulmonologist in private practice when he acquired and later merged with two other pulmonary physicians’ practices to become part of Consultants For Lung Disease, Inc. By 1995, he served as a director, chairman and Chief Executive Officer, and later as Chief Medical Officer of North Hollywood, California-based IPC Healthcare Inc., previously known as IPC-The Hospitalist Co. In 1998, Dr. Singer was named an Up & Comer by Modern Healthcare. In 2008, Dr. Singer was named Modern Physician’s first-ever Physician Entrepreneur of the Year, and in 2009, he was recognized as the Regional Ernst & Young Entrepreneur of the Year. Dr. Singer received his B.S. in biology from the University of California, Los Angeles and his medical degree from the Chicago Medical School at Rosalind Franklin University. He completed his post-doctoral internship and residency in internal medicine and a fellowship in pulmonary medicine at University of Southern California. He currently sits on the Boards of two companies: MDVIP, which develops concierge medical practices for over 900 physicians, and OB Hospitalist Group, which provides expert inpatient Obstetrical care in over 120 facilities.
Mark C. Throdahl – President & CEO, OrthoPediatrics Corp
Mark Throdahl has more than 30 years of leadership experience in the medical products and supplies industry. He is President & CEO of OrthoPediatrics Corp, an orthopedic products company focused on the pediatric market. Formerly, Mark was Group President of Zimmer Holdings, served as Chief Executive of Consort Medical plc and had a 13 year career at Becton Dickinson where he oversaw a $2 billion division of the Company. His experience with a variety of medical products and supplies has been extremely helpful as Gryphon works to source a platform investment from this large and growing segment of the healthcare industry.